Novartis reported $36.95B in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Alcon AG ALC:SW USD 5.16B 146M
Amgen AMGN:US USD 22.19B 1.88B
Artemis Alpha ATS:LN GBP 5.63M 4.38M
AstraZeneca AZN:LN USD 20.22B 693M
Bayer BAYN:GR EUR 38.41B 1.14B
Biogen BIIB:US USD 9.77B 24.9M
Fresenius FRE:GR EUR 19.44B 625M
Fresenius Medical Care FME:GR EUR 8.51B 407.67M
Galapagos GLPG:NA EUR 4.46B 70.8M
Genmab GEN:DC DKK 28.74B 3.25B
Gilead Sciences GILD:US USD 15.23B 1.67B
GlaxoSmithKline GSK:LN GBP 20.77B 520M
Hikma Pharmaceutical HIK:LN USD 2.14B 50M
Lonza Group LONN:SW CHF 5.72B 13M
Merck MRK:GR EUR 12.94B 527M
Novartis NOVN:VX USD 36.95B 1.19B
Novartis NVS:US USD 36.91B 44M
Orion ORNBV:FH EUR 879.5M 254.7M
Recordati REC:IM EUR 1.24B 20.7M
Regeneron Pharmaceuticals REGN:US USD 22.06B 6.64B
Roche Holding ROG:VX 30.32B 5.31B